Viewing Study NCT05535959


Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2025-12-26 @ 1:39 PM
Study NCT ID: NCT05535959
Status: COMPLETED
Last Update Posted: 2022-12-12
First Post: 2022-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Relative Bioavailability of a Fixed-dose Combination Tablet of VX-121/Tezacaftor/Deutivacaftor
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module